|
|
| Company |
Market |
Revenues |
Net Income |
|
Cap1 |
TTM2 |
TTM2 |
| Celera Genomics (CRA) |
1018.0 |
88.1 |
(81.9) |
| CuraGen Corp. (CRGN) |
364.0 |
8.2 |
(85.9) |
| deCODE Genetics Inc. (DCGN) |
441.9 |
52.7 |
(35.4) |
| DNAPrint Genomics (DNAP.OB) |
36.4 |
0.6 |
(5.8) |
| Exelixis Inc. (EXEL) |
501.1 |
50.3 |
(92.4) |
| Genome Therapeutics Corp. (GENE) |
98.4 |
13.1 |
(37.3) |
| Human Genome Sciences (HGSI) |
1712.0 |
4.2 |
(196.2) |
| Nuvelo (NUVO) |
266.6 |
5.4 |
(57.3) |
| Incyte Genomics Inc. (INCY) |
495.6 |
57.9 |
(193.2) |
| Interleukin Genetics Inc. (ILGN) |
108.1 |
1.5 |
(4.5) |
| Lexicon Genetics Inc. (LEXG) |
369.8 |
39.2 |
(63.2) |
| Millennium Pharmaceuticals (MLNM) |
5619.1 |
445.1 |
(417.0) |
| Myriad Genetics Inc. (MYGN) |
348.4 |
62.5 |
(29.1) |
| Rigel Pharmaceuticals Inc. (RIGL) |
284.0 |
12.7 |
(37.4) |
| Sequenom Inc. (SQNM) |
127.9 |
30.0 |
(72.5) |
| Vertex Pharmaceuticals (VRTX) |
804.2 |
102.3 |
(257.1) |
| Q4 2003 Index = 12,596 |
|
|
|
|
|
| Company |
Market |
Revenues |
Net Income |
|
Cap1 |
TTM2 |
TTM2 |
| Aclara Biosciences (ACLA) |
130.7 |
1.6 |
(23.4) |
| Affymetrix Inc. (AFFX) |
1459.9 |
289.9 |
1.2 |
| Applied Biosystems Group (ABI) |
4308.3 |
1692.0 |
181.4 |
| Ciphergen Biosystems (CIPH) |
329.9 |
56.8 |
(36.7) |
| Compugen Ltd. (CGEN) |
131.2 |
10.2 |
(11.1) |
| Epoch Biosciences Inc. (EBIO) |
59.4 |
10.7 |
(4.2) |
| Harvard Bioscience Inc. (HBIO) |
267.9 |
81.8 |
1.5 |
| Illumina Inc. (ILMN) |
231.6 |
21.2 |
(30.7) |
| Invitrogen Corp. (IVGN) |
3571.7 |
731.8 |
57.7 |
| LION bioscience AG (ADR) (LEON) |
73.7 |
26.6 |
(192.5) |
| Luminex Corp. (LMNX) |
283.6 |
21.9 |
(9.9) |
| Qiagen N.V. (QGENF) |
1747.6 |
334.5 |
35.7 |
| Third Wave Technologies (TWTI) |
181.1 |
34.3 |
(7.0) |
| Transgenomic Inc. (TBIO) |
51.2 |
34.7 |
(23.7) |
| Varian Inc. (VARI) |
1443.5 |
848.7 |
49.2 |
| Q4 2003 Index = 14,271 |
|
|
|
1) Market cap is the number of shares outstanding x share price as of Dec. 31, 2003 (in $ millions).
2) TTM is trailing 12 months ending Sept. 30, 2003, for all companies (all financials in $ millions).
RCW Mirus Inc. does not assume any liability for errors or omissions.
Back to On the Up and Up